Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
ACADIA Pharmaceuticals Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
ACAD
Nasdaq
2836
www.acadia.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for ACADIA Pharmaceuticals Inc.
HRMY or ACAD: Which Is the Better Value Stock Right Now?
- Jul 30th, 2026 9:40 am
ACADIA Pharmaceuticals (ACAD) Stock Still Looks Below Fair Value Despite Clinical Risk
- Jul 30th, 2026 6:09 am
Royalty Pharma (RPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Jul 29th, 2026 8:00 am
Acadia Pharmaceuticals (ACAD) Expected to Beat Earnings Estimates: Should You Buy?
- Jul 28th, 2026 8:00 am
The Zacks Analyst Blog Highlights CVS Health, Cardinal Health, Humana and ACADIA Pharmaceuticals
- Jul 28th, 2026 3:02 am
The Zacks Analyst Blog Highlights Harmony Biosciences, Acadia Pharmaceuticals, Biogen, Insmed and Agios Pharmaceuticals
- Jul 28th, 2026 2:58 am
Watch These 5 Biotech Stocks for Q2 Earnings: Beat or Miss?
- Jul 27th, 2026 10:36 am
4 Medical Stocks With the Right Setup for Q2 Earnings Beats
- Jul 27th, 2026 10:03 am
Neurocrine Gears Up to Report Q2 Earnings: What's in the Cards?
- Jul 27th, 2026 9:11 am
Wall Street Analysts Believe Acadia (ACAD) Could Rally 30.89%: Here's is How to Trade
- Jul 23rd, 2026 7:55 am
Acadia Gets FDA's Fast Track Tag for Alzheimer's Disease Candidate
- Jul 21st, 2026 8:47 am
Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis
- Jul 20th, 2026 7:05 am
Acadia Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 4, 2026
- Jul 15th, 2026 2:05 pm
An Acadia Pharmaceuticals Insider Sold Nearly Half Their Shares in the Company. What Does That Mean for Investors?
- Jul 11th, 2026 3:10 pm
ACADIA Pharmaceuticals (ACAD) Names A New Chief People Officer, Is It Still Below Fair Value?
- Jul 10th, 2026 8:09 pm
Is ACADIA Pharmaceuticals (ACAD) Still Undervalued After The Daybue Win?
- Jul 10th, 2026 8:15 am
How CHMP’s Positive Rett Syndrome Ruling on DAYBU Could Impact ACADIA Pharmaceuticals (ACAD) Investors
- Jul 10th, 2026 7:12 am
Verastem (VSTM) Surges 6.3%: Is This an Indication of Further Gains?
- Jul 10th, 2026 3:45 am
RPRX or ACAD: Which Is the Better Value Stock Right Now?
- Jul 9th, 2026 9:40 am
Acadia Pharmaceuticals Appoints Carl Segerstrom as Chief People Officer
- Jul 6th, 2026 7:04 am
Scroll